Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We use multi-parametric cardiac magnetic resonance imaging and multinuclear magnetic resonance spectroscopy to non-invasively investigate the relationship between cardiac metabolism and cardiac function.

Multinuclear Imaging of the Heart

The heart is very energetically demanding, using more ATP than any other organ in the body. We are a clinical research group interested in the effects of altering the balance of glucose and fatty acids the heart uses to produce ATP. In order to do this we use 31P and hyperpolarized 13C magnetic resonance spectroscopy to measure metabolism (PDH flux, PCr/ATP, CK flux) and relate this to cardiac lipid content (1H spectroscopy) and cardiac function (cardiac MRI and echocardiography).

We have a wide range of interests. One of our main focuses is the effects of obesity and insulin resistance as this alters the delivery and use of fatty acids and glucose to the heart and the interplay between obesity, substrate metabolism and cardiac function in heart failure. As many of the symptoms of obesity and heart failure occur during exercise we perform metabolic and functional assessment at rest and also during catecholamine stress. We also investigate the beneficial effects of weight loss, both surgical and dietary.

We also investigate the effects of pressure and volume loading on myocardial metabolism, aiming to use these techniques to optimise the timing of surgical valve replacement.

The other main focus of this group is working with Professor Damian Tyler to translate hyperpolarized 13C imaging and spectroscopy into human cardiac studies with a focus on diabetes, ischaemic heart disease, LV hypertrophy and heart failure.

Rider Group members

Selected publications

Lab Alumni

Dr Andrew Lewis

Dr Jenny Rayner 

Dr Mark Peterzan

Dr Andrew Apps

Related research themes